Reported by ScienceDaily
A surprising discovery involving vitamin B12 could open new possibilities for understanding and potentially treating rare genetic disorders. Researchers found that the vitamin can correct developmental problems in tiny worms carrying a genetic mutation associated with Verheij syndrome, a rare human condition that causes developmental delays, impaired growth, and short stature.
The findings center on a cellular process called RNA splicing, which helps prepare the genetic instructions cells use to produce proteins. During splicing, unnecessary portions of messenger RNA are removed, and the remaining sections are joined together in the correct order. When this process goes wrong, it can disrupt essential cellular functions and contribute to serious developmental disorders.
Mutations in genes responsible for splicing can cause conditions such as Verheij syndrome. To better understand the effects of these genetic changes, scientists investigated how a related mutation affects growth and metabolism in a laboratory model.
More from the original report
The discovery emerged from experiments involving C. elegans , a tiny roundworm commonly used in biological research. The researchers were initially searching for previously unknown genes that influence lifespan when they began examining a mutation in a gene involved in RNA splicing. The same gene is associated with Verheij syndrome in humans.
Worms carrying the mutation developed problems resembling important features of the human disorder. Their growth slowed considerably, and they remained smaller than normal.
To investigate why this happened, the scientists conducted genetic screens and analyzed the worms' metabolism. They discovered that the mutation disrupted specific metabolic pathways that depend on vitamin B12 and are essential for healthy growth and normal cellular activity.
The researchers then tested whether providing additional vitamin B12 could counteract these changes. Remarkably, the treatment restored the affected metabolic processes to normal and corrected the developmental abnormalities associated with the mutation.
"We were surprised to find that a change in a fundamental process of RNA processing had such a targeted effect on vitamin B12-dependent metabolism," says Jonathan Kölschbach, first author of the study. "Even more exciting was that we were able to largely correct the consequences of this change in the worm model using vitamin B12."
To explore whether their…
